Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kenneth C Anderson

Showing results (531-540 of 869) with videos related to

Pageof 87
Sort By:
British Journal of Haematology|May 8, 2013
TRIM13 (RFP2) downregulation decreases tumour cell growth in multiple myeloma through inhibition of NF Kappa B pathway and proteasome activityMoshe E Gatt, Kohichi Takada, Mala Mani, et al.
Blood|November 18, 2021
IgM-MM is predominantly a pre-germinal center disorder and has a distinct genomic and transcriptomic signature from WMAbdul Hamid Bazarbachi, Hervé Avet-Loiseau, Raphael Szalat, et al.
Blood|May 28, 2009
Safety and efficacy of single-agent lenalidomide in patients with relapsed and refractory multiple myelomaPaul Richardson, Sundar Jagannath, Mohamad Hussein, et al.
Blood|August 5, 2009
Aurora kinase A is a target of Wnt/beta-catenin involved in multiple myeloma disease progressionJui Dutta-Simmons, Yunyu Zhang, Gullu Gorgun, et al.
British Journal of Haematology|November 7, 2008
In vivo anti-myeloma activity and modulation of gene expression profile induced by valproic acid, a histone deacetylase inhibitorPaola Neri, Pierosandro Tagliaferri, Maria Teresa Di Martino, et al.
Cancer Research|March 15, 2024
Retraction: Insulin-like Growth Factor-1 Induces Adhesion and Migration in Human Multiple Myeloma Cells via Activation of β1-Integrin and Phosphatidylinositol 3'-Kinase/AKT SignalingYu-Tzu Tai, Klaus Podar, Laurence Catley, et al.
British Journal of Haematology|May 30, 2012
Perifosine plus lenalidomide and dexamethasone in relapsed and relapsed/refractory multiple myeloma: a Phase I Multiple Myeloma Research Consortium studyAndrzej J Jakubowiak, Paul G Richardson, Todd Zimmerman, et al.
Blood|April 30, 2016
APRIL and BCMA promote human multiple myeloma growth and immunosuppression in the bone marrow microenvironmentYu-Tzu Tai, Chirag Acharya, Gang An, et al.
Blood|May 5, 2005
Honokiol overcomes conventional drug resistance in human multiple myeloma by induction of caspase-dependent and -independent apoptosisKenji Ishitsuka, Teru Hideshima, Makoto Hamasaki, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 11, 2007
WIP is a chaperone for Wiskott-Aldrich syndrome protein (WASP)Miguel A de la Fuente, Yoji Sasahara, Marco Calamito, et al.
Pageof 87

Showing results (531-540 of 869) with videos related to

Sort By:
Pageof 87
British Journal of Haematology|May 8, 2013
TRIM13 (RFP2) downregulation decreases tumour cell growth in multiple myeloma through inhibition of NF Kappa B pathway and proteasome activityMoshe E Gatt, Kohichi Takada, Mala Mani, et al.
Blood|November 18, 2021
IgM-MM is predominantly a pre-germinal center disorder and has a distinct genomic and transcriptomic signature from WMAbdul Hamid Bazarbachi, Hervé Avet-Loiseau, Raphael Szalat, et al.
Blood|May 28, 2009
Safety and efficacy of single-agent lenalidomide in patients with relapsed and refractory multiple myelomaPaul Richardson, Sundar Jagannath, Mohamad Hussein, et al.
Blood|August 5, 2009
Aurora kinase A is a target of Wnt/beta-catenin involved in multiple myeloma disease progressionJui Dutta-Simmons, Yunyu Zhang, Gullu Gorgun, et al.
British Journal of Haematology|November 7, 2008
In vivo anti-myeloma activity and modulation of gene expression profile induced by valproic acid, a histone deacetylase inhibitorPaola Neri, Pierosandro Tagliaferri, Maria Teresa Di Martino, et al.
Cancer Research|March 15, 2024
Retraction: Insulin-like Growth Factor-1 Induces Adhesion and Migration in Human Multiple Myeloma Cells via Activation of β1-Integrin and Phosphatidylinositol 3'-Kinase/AKT SignalingYu-Tzu Tai, Klaus Podar, Laurence Catley, et al.
British Journal of Haematology|May 30, 2012
Perifosine plus lenalidomide and dexamethasone in relapsed and relapsed/refractory multiple myeloma: a Phase I Multiple Myeloma Research Consortium studyAndrzej J Jakubowiak, Paul G Richardson, Todd Zimmerman, et al.
Blood|April 30, 2016
APRIL and BCMA promote human multiple myeloma growth and immunosuppression in the bone marrow microenvironmentYu-Tzu Tai, Chirag Acharya, Gang An, et al.
Blood|May 5, 2005
Honokiol overcomes conventional drug resistance in human multiple myeloma by induction of caspase-dependent and -independent apoptosisKenji Ishitsuka, Teru Hideshima, Makoto Hamasaki, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 11, 2007
WIP is a chaperone for Wiskott-Aldrich syndrome protein (WASP)Miguel A de la Fuente, Yoji Sasahara, Marco Calamito, et al.
Pageof 87